This podcast episode explores the fundamentals of Current Good Manufacturing Practices (cGMP) in pharmaceutical production, with a special focus on emerging cannabinoid and psychedelic therapies. The discussion covers key aspects of cGMP including documentation, quality control, facility standards, and personnel training. The episode delves into historical examples like the thalidomide tragedy to illustrate why strict manufacturing standards are crucial. It also addresses current challenges in maintaining product safety, including the management of impurities and the importance of third-party testing. The conversation emphasizes how cGMP helps build trust in new therapeutic areas while ensuring consistent product quality and safety.